Verrica Pharmaceuticals Inc. (VRCA) › Operating Cash FlowVerrica Pharmaceuticals Inc. (VRCA) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2017: -$4.58M2018: -$17.87M2019: -$27.41M2020: -$30.21M2021: -$27.58M2022: -$18.65M2023: -$38.58M2024: -$60.93M2025: -$17.63M-$17.63M2017Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$17.63M+71.1%2024-$60.93M-57.9%2023-$38.58M-106.8%2022-$18.65M+32.4%2021-$27.58M+8.7%2020-$30.21M-10.2%2019-$27.41M-53.3%2018-$17.87M-290.0%2017-$4.58M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share